Buscarini, E., Botella, L. M., Geisthoff, U., Kjeldsen, A. D., Mager, H. J., Pagella, F., . . . Shovlin, C. L. (2019). Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.
Citación estilo ChicagoBuscarini, Elisabetta, et al. Safety of Thalidomide and Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia. 2019.
Cita MLABuscarini, Elisabetta, et al. Safety of Thalidomide and Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia. 2019.
Precaución: Estas citas no son 100% exactas.